NANO-CAN — NANOFTONIC CANCER FOR FIGHTING CANCER (Q2023743): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations)
(‎Removed claims)
Property / EU contribution
2,821,849.8 Euro
Amount2,821,849.8 Euro
UnitEuro
 
Property / EU contribution: 2,821,849.8 Euro / rank
Normal rank
 
Property / budget
3,762,466.4 Euro
Amount3,762,466.4 Euro
UnitEuro
 
Property / budget: 3,762,466.4 Euro / rank
Normal rank
 
Property / co-financing rate
75.0 percent
Amount75.0 percent
Unitpercent
 
Property / co-financing rate: 75.0 percent / rank
Normal rank
 

Revision as of 04:02, 9 February 2022

Project Q2023743 in Italy
Language Label Description Also known as
English
NANO-CAN — NANOFTONIC CANCER FOR FIGHTING CANCER
Project Q2023743 in Italy

    Statements

    country
    Italy
    0 references
    start time
    1 January 2018
    0 references
    expected end time
    31 December 2020
    0 references
    beneficiary name (string)
    CERICT SCRL - CENTRO REGIONALE INFORMATION COMMUNICATION TECHNOLOGY
    0 references
    TEORESI S.P.A
    0 references
    BIOPOX S.R.L
    0 references
    REGIONE CAMPANIA
    0 references
    TECNO-BIOS SRL
    0 references
    beneficiary
    Q278448
    0 references
    Q278449
    0 references
    Q278450
    0 references
    Campania
    0 references
    Q278451
    0 references
    programme
    Campania - ERDF
    0 references
    summary
    L'OBIETTIVO PRINCIPALE RIGUARDA LO SVILUPPO DI PIATTAFORME INNOVATIVE PER LA TERANOSTICA IN VIVO BASATE SU TECNOLOGIA AVANZATA IN FIBRA OTTICA, ATTRAVERSO UN SOLO DISPOSITIVO, OTTENUTO MEDIANTE INTEGRAZIONE DI DIVERSI PROBE MULTIFUNZIONALI IN FIBRA, INGEGNERIZZATI PER LA SPECIFICA APPLICAZIONE E INTEGRATI IN AGHI MEDICALI. SARà POSSIBILE AVERE UN UNICO STRUMENTO CAPACE DI EFFETTUARE CONTEMPORANEAMENTE DIAGNOSI E TERAPIA, OSSIA TERANOSTICA, IN VIVO, ALL'INTERNO DEL CORPO DEL PAZIENTE. (Italian)
    0 references
    THE MAIN OBJECTIVE CONCERNS THE DEVELOPMENT OF INNOVATIVE PLATFORMS FOR IN VIVO THERANOSTICS BASED ON OPTICAL FIBRE ADVANCED TECHNOLOGY, THROUGH A SINGLE DEVICE, WHICH IS ACHIEVED THROUGH THE INTEGRATION OF SEVERAL DIFFERENT FIBRES OF FIBRE, ENGINEERED FOR THE SPECIFIC APPLICATION AND INTEGRATED IN MEDICAL NEEDLES. IT WILL BE POSSIBLE TO HAVE A SINGLE INSTRUMENT CAPABLE OF SIMULTANEOUSLY DIAGNOSING AND TREATING THE PATIENT, IN VIVO, WITHIN THE BODY OF THE PATIENT. (English)
    0 references
    L’OBJECTIF PRINCIPAL EST LE DÉVELOPPEMENT DE PLATES-FORMES TERANOSTIC INNOVANTES IN VIVO BASÉES SUR LA TECHNOLOGIE DE POINTE DE LA FIBRE OPTIQUE, À TRAVERS UN DISPOSITIF UNIQUE, OBTENU PAR L’INTÉGRATION DE PLUSIEURS SONDES À FIBRES MULTIFONCTIONNELLES, CONÇUES POUR L’APPLICATION SPÉCIFIQUE ET INTÉGRÉES DANS DES AIGUILLES MÉDICALES. IL SERA POSSIBLE D’AVOIR UN SEUL INSTRUMENT CAPABLE DE FAIRE SIMULTANÉMENT DIAGNOSTIC ET THÉRAPIE, I.E. TERANOSTIC, IN VIVO, À L’INTÉRIEUR DU CORPS DU PATIENT. (French)
    point in time
    14 December 2021
    0 references
    HET BELANGRIJKSTE DOEL IS DE ONTWIKKELING VAN INNOVATIEVE IN VIVO TERANOSTIC PLATFORMS OP BASIS VAN GEAVANCEERDE GLASVEZELTECHNOLOGIE, DOOR MIDDEL VAN EEN ENKEL APPARAAT, VERKREGEN DOOR DE INTEGRATIE VAN VERSCHILLENDE MULTIFUNCTIONELE VEZELSONDES, ONTWORPEN VOOR DE SPECIFIEKE TOEPASSING EN GEÏNTEGREERD IN MEDISCHE NAALDEN. HET ZAL MOGELIJK ZIJN OM EEN ENKEL INSTRUMENT IN STAAT OM GELIJKTIJDIG DIAGNOSE EN THERAPIE, I.E. TERANOSTIC, IN VIVO, IN HET LICHAAM VAN DE PATIËNT. (Dutch)
    point in time
    23 December 2021
    0 references
    DAS HAUPTZIEL IST DIE ENTWICKLUNG INNOVATIVER IN VIVO TERANOSTIC-PLATTFORMEN, DIE AUF FORTSCHRITTLICHER GLASFASERTECHNOLOGIE BASIEREN, DURCH EIN EINZIGES GERÄT, DAS DURCH DIE INTEGRATION MEHRERER MULTIFUNKTIONALER FASERSONDEN, ENTWICKELT FÜR DIE SPEZIFISCHE ANWENDUNG UND IN MEDIZINISCHE NADELN INTEGRIERT WIRD. ES WIRD MÖGLICH SEIN, EIN EINZIGES INSTRUMENT ZUR GLEICHZEITIGEN DIAGNOSE UND THERAPIE, I.E. TERANOSTIC, IN VIVO, IM KÖRPER DES PATIENTEN ZU HABEN. (German)
    point in time
    24 December 2021
    0 references
    EL OBJETIVO PRINCIPAL ES EL DESARROLLO DE INNOVADORAS PLATAFORMAS TERANOSTIC IN VIVO BASADAS EN TECNOLOGÍA AVANZADA DE FIBRA ÓPTICA, A TRAVÉS DE UN ÚNICO DISPOSITIVO, OBTENIDA MEDIANTE LA INTEGRACIÓN DE VARIAS SONDAS DE FIBRA MULTIFUNCIONAL, DISEÑADAS PARA LA APLICACIÓN ESPECÍFICA E INTEGRADAS EN AGUJAS MÉDICAS. SERÁ POSIBLE DISPONER DE UN ÚNICO INSTRUMENTO CAPAZ DE REALIZAR SIMULTÁNEAMENTE EL DIAGNÓSTICO Y LA TERAPIA, I.E. TERANOSTIC, IN VIVO, DENTRO DEL CUERPO DEL PACIENTE. (Spanish)
    point in time
    24 January 2022
    0 references

    Identifiers

    Italian Unique Project Code
    B51C17000050007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2023743&oldid=27441567"